Holen Sie sich die Stockscreener-App
32.27
0.92%
0.32
Edgewise Therapeutics Inc Aktie (EWTX) Neueste Nachrichten
FY2024 Earnings Estimate for EWTX Issued By Leerink Partnrs - Defense World
What is Leerink Partnrs' Forecast for EWTX FY2024 Earnings? - MarketBeat
Orbimed Advisors LLC Adjusts Stake in Edgewise Therapeutics Inc - GuruFocus.com
FMR LLC Reduces Stake in Edgewise Therapeutics Inc - GuruFocus.com
Learn to Evaluate (EWTX) using the Charts - Stock Traders Daily
Edgewise Therapeutics Reports Third Quarter Financial Results and Business Highlights - Defense World
Edgewise Therapeutics (NASDAQ:EWTX) Price Target Raised to $45.00 - MarketBeat
Edgewise Therapeutics Reports Q3 Progress in Muscle Disease Trials - TipRanks
Edgewise Therapeutics Inc. (EWTX) Quarterly 10-Q Report - Quartzy
Edgewise boosts R&D spending with drug trials underway - BizWest
Edgewise Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Edgewise Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights - BioSpace
Edgewise Therapeutics stock hits 52-week high at $36.71 - Investing.com
Edgewise Therapeutics stock hits 52-week high at $36.71 By Investing.com - Investing.com UK
Critical Analysis: Prestige Consumer Healthcare (NYSE:PBH) versus Edgewise Therapeutics (NASDAQ:EWTX) - Defense World
abrdn plc Purchases Shares of 256,645 Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Edgewise Therapeutics shares maintain price target on positive data By Investing.com - Investing.com Australia
Novo Holdings A S Sells 794,530 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Moody Aldrich Partners LLC Makes New Investment in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Edgewise Therapeutics stock hits 52-week high at $35.34 - Investing.com
Edgewise Therapeutics stock hits 52-week high at $35.34 By Investing.com - Investing.com Canada
Edgewise Therapeutics Inc (EWTX)’s Market Momentum: Closing Strong at 32.99, Up 3.68 - The Dwinnex
Top investors say Edgewise Therapeutics Inc (EWTX) ticks everything they need - SETE News
Edgewise Therapeutics (NASDAQ:EWTX) Reaches New 52-Week HighShould You Buy? - MarketBeat
Is it possible to buy Edgewise Therapeutics Inc(EWTX) shares at a good price now? - US Post News
EWTX (Edgewise Therapeutics Inc) may reap gains as insiders became active recently - Knox Daily
SG Americas Securities LLC Sells 34,544 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Piper Sandler Increases Edgewise Therapeutics (NASDAQ:EWTX) Price Target to $51.00 - Defense World
Minimal stock impact anticipated for Edgewise Therapeutics stock even with potential CK miss - Investing.com Canada
Edgewise Therapeutics (NASDAQ:EWTX) Shares Up 4.5% Following Analyst Upgrade - MarketBeat
Edgewise Therapeutics (NASDAQ:EWTX) Price Target Raised to $51.00 at Piper Sandler - MarketBeat
(EWTX) Technical Pivots with Risk Controls - Stock Traders Daily
Edgewise Therapeutics Inc (EWTX) Stock: Navigating Drops and Gains - The InvestChronicle
Chief Scientific Officer Russell Alan J sold 75,000 shares of Edgewise Therapeutics Inc [EWTX] - Knox Daily
Edgewise Therapeutics (NASDAQ:EWTX) Hits New 12-Month HighTime to Buy? - MarketBeat
A look into Edgewise Therapeutics Inc (EWTX)’s deeper side - SETE News
Financial Analysis: Edgewise Therapeutics Inc (EWTX)’s Ratios Unveil Key Insights - The Dwinnex
Was there any good news for Edgewise Therapeutics Inc (EWTX) stock in the last session? - US Post News
Dimensional Fund Advisors LP Buys 168,219 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Edgewise Therapeutics, Inc. (EWTX): A Hot Stock to Buy Now - Yahoo Finance
Edgewise Therapeutics (NASDAQ:EWTX) Shares Gap Down – Here’s What Happened - Defense World
Edgewise Therapeutics (NASDAQ:EWTX) Shares Gap DownHere's What Happened - MarketBeat
Edgewise Therapeutics Inc [EWTX] Insider Activity: An Update for Investors - Knox Daily
Squarepoint Ops LLC Purchases 27,687 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - Defense World
Millennium Management LLC Purchases 613,251 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Edgewise Therapeutics (NASDAQ:EWTX) Trading 5.2% HigherStill a Buy? - MarketBeat
Edgewise Therapeutics (NASDAQ:EWTX) Trading 5.2% Higher – Still a Buy? - Defense World
Hypertrophic Cardiomyopathy Market Expected to Experience - openPR
Hypertrophic Cardiomyopathy Market Expected to Experience Major Growth by 2034, According to DelveInsight | Edgewise Therapeutics, Inc., Lexicon Pharmaceuticals, Shandong Suncadia Medicine, Ji Xing - Barchart
Edgewise Therapeutics Insiders Sold US$2.6m Of Shares Suggesting Hesitancy - Simply Wall St
Chief Scientific Officer Russell Alan J sale 75,000 shares of Edgewise Therapeutics Inc [EWTX] - Knox Daily
Marshall Wace LLP Grows Holdings in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - Defense World
Dark Forest Capital Management LP Makes New $193,000 Investment in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - Defense World
Edgewise Therapeutics to Present on Sevasemten (EDG-5506) for Becker Muscular Dystrophy (Becker) at the 29th International Annual Congress of the World Muscle Society - StockTitan
Marshall Wace LLP Boosts Stock Position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Balance Sheet Breakdown: Edgewise Therapeutics Inc (EWTX)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex
1.80%
0.42%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):